Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
411 studies found for:    "Spondylarthropathy"
Show Display Options
Rank Status Study
1 Completed Evaluation of a Protocol for Dose Reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF
Condition: Spondylarthropathies
Interventions: Drug: Reduced doses of anti-TNF;   Drug: Stable doses of anti-TNF
2 Completed
Has Results
Study Evaluating Etanercept for the Treatment of Refractory Heel Enthesitis in Spondylarthropathy
Condition: Spondylarthropathies, Enthesitis
Interventions: Drug: Etanercept;   Other: Placebo
3 Enrolling by invitation Unguided Sacroiliac Injection: Effect on Refractory Buttock Pain in Patients With Spondyloarthropathies
Condition: Spondylarthropathy
Intervention: Procedure: guide-free sacroiliac corticosteroid injection
4 Completed Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile Spondyloarthropathies
Condition: Spondylarthropathies
Interventions: Drug: infliximab;   Drug: Placebo
5 Completed Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial
Condition: Spondyloarthropathy
Interventions: Drug: golimumab;   Drug: Pamidronate
6 Completed Evaluation of Power Doppler US Technique for the Diagnosis of Spondylarthropathy
Conditions: Spondylarthropathy;   Ankylosing Spondyloarthitis;   Spondyloarthritis
Intervention:
7 Active, not recruiting Safety of Etoricoxib (MK-0663) in Patients With Spondyloarthropathy (SpA)/Ankylosing Spondylitis (AS) in Sweden (EP07013.013.11.082)
Condition: Spondylarthropathies; Spondylitis, Ankylosing
Interventions: Drug: etoricoxib;   Drug: Other COX-2 inhibitor;   Drug: nsNSAIDs
8 Completed TNFalfa Blocking Treatment of Spondylarthropathies
Conditions: Spondylarthropathies;   Ankylosing Spondylitis;   Psoriatic Arthritis
Interventions: Drug: Infliximab;   Drug: Etanercept;   Drug: Adalimumab
9 Terminated
Has Results
Seronegative Oligoarthritis of the Knee Study (SOKS)
Condition: Spondylarthropathies
Interventions: Drug: methylprednisolone;   Drug: Infliximab
10 Completed Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back Pain
Condition: Seronegative Spondyloarthropathies
Interventions: Drug: Methotrexate, Hydroxychloroquine;   Drug: Placebo
11 Not yet recruiting Clinical Characteristics of Importance to Outcome in Patients With Spondyloarthritis
Condition: Spondyloarthropathy
Intervention:
12 Active, not recruiting French Cohort of Undifferentiated Spondyloarthritis
Condition: EARLY UNDIFFERENTIATED SPONDYLARTHROPATHIES
Intervention: Other: Imaging exams
13 Completed Diagnostic Criteria in the Diagnosis of Spinal Spondyloarthropathies in Patients With Chronic Low Back Pain (Study P05320)(COMPLETED)
Conditions: Spinal Spondyloarthropathies;   Axial Spondyloarthritis
Intervention:
14 Enrolling by invitation Effects of Different Anti-rheumatic Treatments of Arthritis on Antibody Response Following Pneumococcal Vaccination Using Prevenar®
Conditions: Rheumatoid Arthritis;   Spondylarthropathy
Intervention: Biological: Prevenar vaccination
15 Completed The Characterization of Small Bowel and Colonic Involvement in Patients With Seronegative Spondyloarthritides
Condition: Spondyloarthropathies
Interventions: Procedure: Capsule endoscopy examination;   Procedure: Colonoscopy
16 Completed
Has Results
Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis
Condition: Spondyloarthropathies
Interventions: Biological: CZP 200 mg Q2W;   Biological: CZP 400 mg Q4W;   Other: Placebo
17 Completed A Study of the Use of the Madrid Ultrasound Scoring System in the Treatment of Anti-TNF Blocker to Peripheral Tendonitis in Patients With Spondyloarthritis
Condition: Spondyloarthropathy
Interventions: Drug: etanercept;   Drug: etanercept (half dose);   Drug: placebo
18 Completed Study Confirms or Refutes the Hypothesis That the Autologous Bone Marrow Concentrate Together With the Allograft is a Better Alternative for the Posterolateral Fusion in Spine Surgery Than the Allograft Alone
Condition: Spondyloarthrosis, Spondylosis
Intervention: Biological: bone allogaft with bone marrow concentrate
19 Withdrawn Methotrexate in the Treatment of Axial Spondyloarthritis
Conditions: Spondylarthropathies;   Spondylitis, Ankylosing
Intervention: Drug: Methotrexate
20 Unknown  Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy
Conditions: Psoriatic Arthritis;   Ankylosing Spondylitis;   Undifferentiated Spondyloarthropathy
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.